- Lobbying
- bluebird AND bio
Lobbying Arrangements Results for 'Bluebird Bio'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details HR 2666 - MVP Act Medicaid Program: Misclassification of Drugs, Program Administration and Program Integrity Updates Under the Medicaid Drug Rebate Program (CMS-2434-P) CMMI sought bluebird input... |
Bluebird Bio, Inc.
|
in-house lobbying | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the gene therapies, drug pricing, and other issues that impact the industry generally, but bluebi... |
bluebird bio
|
Polsinelli PC | |||
Details -Issues relating to gene therapy, value-based arrangements, and the Patient Affordability, Value and Efficacy (PAVE) Act. -Implementation of the Orphan Drug Act of 1983 (P.L. 97-414) and orphan dru... |
Bluebird Bio
|
FOLEY HOAG LLP | |||
Details Provide guidance and strategic counsel with regard to regulations and legislation that could impact the gene therapies, drug pricing and other issues that impact the industry generally, and bluebir... |
bluebird bio
|
BGR Government Affairs | |||
Details Issues and legislation related to access to gene therapies and treatment of rare diseases; the Medicaid VBPs for Patients (MVP) Act (H.R. 2666). |
bluebird bio, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to value based payment and ensuring access to gene therapies. Issues related to rulemaking supporting value based payment arrangements. Monitored drug pricing issues related to H.R. ... |
bluebird bio
|
THE NICKLES GROUP, LLC |